Crossmark

Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing

Crossref DOI link: https://doi.org/10.1007/s00432-023-05011-7

Published Online: 2023-06-28

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Tiewen

Zhou, Zeng

Xie, Zhiwen

Fan, Xuhui

Zhang, Yichen

Zhang, Yu

Song, Xiaodong

Ruan, Yuan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81870516)
License Information

Text and Data Mining valid from 2023-06-28

Version of Record valid from 2023-06-28
More Information

Article History

Received: 11 May 2023

Accepted: 19 June 2023

First Online: 28 June 2023

Declarations

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

: Our study was approved by the Institutional Review Board of Shanghai General Hospital. Moreover, all patients signed an informed consent form.

: Not applicable.

Document is current

Any future updates will be listed below